IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF)'s subsidiary, Imaging Biometrics, has successfully installed its advanced imaging software at Insel Gruppe AG, a hospital group based in Bern, Switzerland. The installation was done through Bayer's Calantic platform, which features Imaging Biometrics' unique algorithms.
This new technology helps doctors make better decisions. It is especially useful for neuroradiologists (brain imaging specialists), oncologists, and surgeons. The software provides precise and reliable imaging, helping them choose the best treatment quickly and effectively.
Dr Arsany Hakim, Head of Brain Tumor Imaging at the Institute of Diagnostic and Interventional Neuroradiology, said: "The incorporation of IB's software into our clinical workflow marks a significant step towards the standardisation of advanced imaging, enhancing both clinical workflow and patient care.
"We are eager to utilise the capabilities offered by IB's solutions in our team to enhance lesion detection and to advance patient monitoring process, ultimately to improve patient outcomes."